Literature DB >> 23956685

Self-report of illicit substance use versus urine toxicology results from at-risk pregnant women.

Kimberly A Yonkers1, Heather B Howell, Nathan Gotman, Bruce J Rounsaville.   

Abstract

INTRODUCTION: Many factors comprise a patient's decision to disclose use of drugs. Pregnant women may report drug use because they would like help with their addiction but the stigma associated with drug use may dampen their willingness to disclose. Knowledge about the accuracy of self-reported drug use as compared to urine toxicology screens can assist clinicians in the management of substance use in pregnancy.
METHOD: We compared the urine toxicology screens and self-reported use of marijuana or cocaine for 168 women enrolled in an integrated obstetrical/substance abuse treatment program. We stratified by various periods of self-reported use and race and utilized Cohen's kappa to measure overall agreement between self-report and toxicology tests.
RESULTS: Most women with a positive toxicology screen reported use in the past 28 days (78% for marijuana, 86% for cocaine). However, many women reported their most recent use to be outside of the assays' detection window (14% for marijuana, 57% for cocaine). We did not find differences in self-report for women with positive urine between Whites and non-Whites (p = 1.00). Agreement over the previous month was good (Kappa = 0.74 and 0.70 for marijuana and cocaine, respectively.).
SUMMARY: A question about use of marijuana or cocaine during the preceding month rather than the prior few days may be a better indicator of use.

Entities:  

Keywords:  Cocaine; marijuana; self-disclosure; urine toxicology

Year:  2011        PMID: 23956685      PMCID: PMC3744375          DOI: 10.3109/14659891003721133

Source DB:  PubMed          Journal:  J Subst Use        ISSN: 1465-9891


  34 in total

1.  Cocaine-exposed infants and developmental outcomes: "crack kids" revisited.

Authors:  Barry Zuckerman; Deborah A Frank; Linda Mayes
Journal:  JAMA       Date:  2002-04-17       Impact factor: 56.272

2.  Pregnancy-related substance use in the United States during 1996-1998.

Authors:  Shahul H Ebrahim; Joseph Gfroerer
Journal:  Obstet Gynecol       Date:  2003-02       Impact factor: 7.661

3.  Talk is cheap: measuring drinking outcomes in clinical trials.

Authors:  T F Babor; K Steinberg; R Anton; F Del Boca
Journal:  J Stud Alcohol       Date:  2000-01

4.  Use of a bogus pipeline method to increase accuracy of self-reported alcohol consumption among pregnant women.

Authors:  J B Lowe; R A Windsor; B Adams; J Morris; Y Reese
Journal:  J Stud Alcohol       Date:  1986-03

5.  Declared and undeclared substance use among emergency department patients: a population-based study.

Authors:  Ian R H Rockett; Sandra L Putnam; Haomiao Jia; Gordon S Smith
Journal:  Addiction       Date:  2006-05       Impact factor: 6.526

6.  The TWEAK: application in a prenatal setting.

Authors:  G Chang; L Wilkins-Haug; S Berman; M A Goetz
Journal:  J Stud Alcohol       Date:  1999-05

7.  The substance abuse subtle screening inventory is more cost effective and has better selectivity than urine toxicology for the detection of substance abuse in pregnancy.

Authors:  T J Horrigan; N J Piazza; L Weinstein
Journal:  J Perinatol       Date:  1996 Sep-Oct       Impact factor: 2.521

8.  Cocaine in the hair of mother-infant pairs: quantitative analysis and correlations with urine measures and self-report.

Authors:  P R Marques; A S Tippetts; D G Branch
Journal:  Am J Drug Alcohol Abuse       Date:  1993       Impact factor: 3.829

Review 9.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

10.  Monitoring patterns of substance use in drug-dependent patients.

Authors:  L San; M Torrens; J Tato; C Castillo; R de la Torre; B Arranz
Journal:  J Subst Abuse Treat       Date:  1998 Sep-Oct
View more
  16 in total

1.  Validity of Self-Reported Drug Use Information Among Pregnant Women.

Authors:  Mahek Garg; Laura Garrison; Lawrence Leeman; Ajna Hamidovic; Matthew Borrego; William F Rayburn; Ludmila Bakhireva
Journal:  Matern Child Health J       Date:  2016-01

2.  Perinatal smoking and depression in women with concurrent substance use.

Authors:  Ariadna Forray; Nathan Gotman; Trace Kershaw; Kimberly A Yonkers
Journal:  Addict Behav       Date:  2013-12-17       Impact factor: 3.913

3.  Utility of Point-of-care Urine Drug Tests in the Treatment of Primary Care Patients With Drug Use Disorders.

Authors:  Michael G McDonell; Meredith C Graves; Imara I West; Richard K Ries; Dennis M Donovan; Kristin Bumgardner; Antoinette Krupski; Chris Dunn; Charles Maynard; David C Atkins; Peter Roy-Byrne
Journal:  J Addict Med       Date:  2016 May-Jun       Impact factor: 3.702

4.  Association Between Self-reported Prenatal Cannabis Use and Maternal, Perinatal, and Neonatal Outcomes.

Authors:  Daniel J Corsi; Laura Walsh; Deborah Weiss; Helen Hsu; Darine El-Chaar; Steven Hawken; Deshayne B Fell; Mark Walker
Journal:  JAMA       Date:  2019-07-09       Impact factor: 56.272

5.  What is the prevalence of drug use in the general population? Simulating underreported and unknown use for more accurate national estimates.

Authors:  Natalie S Levy; Joseph J Palamar; Stephen J Mooney; Charles M Cleland; Katherine M Keyes
Journal:  Ann Epidemiol       Date:  2022-01-03       Impact factor: 6.996

6.  Antecedents of the child behavior checklist-dysregulation profile in children born extremely preterm.

Authors:  Jean A Frazier; Mollie E Wood; Janice Ware; Robert M Joseph; Karl C Kuban; Michael O'Shea; Elizabeth N Allred; Alan Leviton
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2015-08-04       Impact factor: 8.829

7.  Cannabis Use during Pregnancy and Risk of Adverse Birth Outcomes: A Longitudinal Cohort Study.

Authors:  Roman Gabrhelík; Milada Mahic; Ingunn Olea Lund; Jørgen Bramness; Randi Selmer; Eva Skovlund; Marte Handal; Svetlana Skurtveit
Journal:  Eur Addict Res       Date:  2020-10-09       Impact factor: 3.015

8.  Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after delivery.

Authors:  Kimberly A Yonkers; Ariadna Forray; Heather B Howell; Nathan Gotman; Trace Kershaw; Bruce J Rounsaville; Kathleen M Carroll
Journal:  Gen Hosp Psychiatry       Date:  2012-07-12       Impact factor: 3.238

9.  Postpartum Marijuana Use, Perceptions of Safety, and Breastfeeding Initiation and Duration: An Analysis of PRAMS Data From Seven States, 2017.

Authors:  Kelsey C Coy; Sarah C Haight; Erica Anstey; Althea M Grant; Nan Ruffo; Jean Y Ko
Journal:  J Hum Lact       Date:  2021-02-13       Impact factor: 2.219

10.  Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation.

Authors:  Uma M Reddy; Jonathan M Davis; Zhaoxia Ren; Michael F Greene
Journal:  Obstet Gynecol       Date:  2017-07       Impact factor: 7.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.